A family of covariance models for longitudinal counts with predictive covariates is presented. These models account for overdispersion, heteroscedasticity, and dependence among repeated observations. The approach is a quasi-likelihood regression similar to the formulation given by Liang and Zeger (1986, Biomnetrika 73, 13-22). Generalized estimating equations for both the covariate parameters and the variance-covariance parameters are presented. Large-sample properties of the parameter estimates are derived. The proposed methods are illustrated by an analysis of epileptic seizure count data arising from a study of progabide as an adjuvant therapy for partial seizures.
Introduction
Consider a longitudinal data set consisting of a count response variable Yi, and a p x 1 vector Xi, of covariates observed at times t = 1, . .. , ni, for independent subjects i = 1, . . ..
M. Such data frequently arise in the clinical testing of new drugs, as well as other areas of application.
When there is a single response for each subject, i.e., all ni = 1, generalized linear models (Nelder and Wedderburn, 1972; McCullagh and Nelder, 1983 ) are broadly applicable. However, data involving counts taken from biological units often exhibit variability exceeding that explained by exponential family probability models. In many circumstances, this can be modelled by unobserved random effects acting on the responses. The main problem faced by the scientist in such settings is identification of the linear predictor in the model. Several authors have stressed the importance of accounting for overdispersion and heteroscedasticity in order to correctly test elements of the linear component. The quasilikelihood approach to this problem was first introduced by Wedderburn (1974) .
For repeated outcomes, where ni > 1, Liang and Zeger (1986) and Zeger and Liang (1986) have proposed quasi-likelihood models that describe the correlation structure among the responses, while also taking overdispersion into account. In the present article, we develop a means of postulating parametric forms for the within-subject covaiiance matrix and carrying out parameter estimation under the general framework of McCullagh (1983) , and more specifically that of Liang and Zeger. We are motivated in part by circumstances wherein the nature and degree of the variability of the phenomenon over time may be as important as its average behavior.
For ease of notation we shall write ni = n. Modifications to accommodate partially missing data are straightforward, provided they are missing completely at random. To links other than log(,ui,) = ,, such as those obtained from the family suggested by Pregibon (1980) The principal objective here is to present tractable parametric forms for V = V(O) that account for heteroscedasticity, overdispersion relative to Poisson marginals, and dependence among the elements of each Yi. In addition to the assumed independence of the response vectors YI, . . . , YAI, we shall require that E(S) = 0, i.e., that the link g and linear components { } are correct. The joint distribution of the entries of each Yi is specified only up to second moments. We derive V heuristically by including random effects for subject and time in each nil and mixing over these effects. Estimation is carried out by alternating between solution of moment equations for the vector a and the equations (1) for fi. An asymptotic distribution theory for the estimators then allows formal testing and subsequent remodelling of both g and V, as functions of a and ,8. Our formulation is analogous to that of Prentice (1988) , who provides a quasi-likelihood framework for correlated binary responses with covariates. He derives the joint distribution of the regression and covariance parameters under a generalized estimating equation formulation that models both the pairwise correlations p (Z) and the marginal probabilities r (Z) as functions of the covariates.
In Section 2 we present a heuristic derivation of V based on random effects that act multiplicatively on the mean. Parameter estimation is described in Section 3, and a joint asymptotic distribution theory for8 ~and & is provided. In Section 4 we present several other forms of V suggested by the initial structure derived in Section 2. To illustrate our methods, an application to the analysis of epileptic seizure count data arising in a study of progabide as an adjuvant antiepileptic chemotherapy is presented in Section 5. Related methods are discussed in Section 6, including estimation of a via pseudo-likelihood (Davidian and Carroll, 1987 ) and the quasi-likelihood approach of Prentice.
A Covariance Matrix
Denote o-2 = var(Yi,) (1 -t S n) and oi,,, = cov(Yi,, Yi,) (t < Iu). Consider the case of counts exhibiting extra-Poisson variation, in that K2,> ,ui,. This may be checked empirically by comparing the sample mean and variance of I Yi,; 1 S i -M} for each t.
We derive an initial form for V under the following assumptions. Let VI..? } be independent and identically distributed subject effects and {I I, . . ., A,, } independent time effects, all unobserved and positive-valued. The two sets of effects are mutually independent. Conditional on these random effects, the responses are independent within subject and 
where J denotes the n x n matrix of 1's. This corresponds to the usual linear model having 
Estimation
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Example
As an illustration, we present analyses of data arising from a clinical trial of 59 epileptics carried out by Leppik et al. (1985) . The data are given in Table 2 . Patients suffering from simple or complex partial seizures were randomized to receive either the antiepileptic drug progabide or a placebo, as an adjuvant to standard chemotherapy. At each of four successive postrandomization clinic visits, the number of seizures occurring over the previous 2 weeks was reported. Although each patient subsequently was crossed over to the other treatment, we shall consider only the four precrossover responses. As shown in Table 3 , the seizure counts exhibit a high degree of extra-Poisson variation, heteroscedasticity, and within-patient dependence.
Each of the first six covariance models given in Table 1 was Table 4 gives the parameter estimates, their standard errors, and the value of log(H) for each model. Convergence was obtained in between five and eight iterations of the twostage estimation procedure for all models shown. For these data, the original model 22 that was derived heuristically in Section 2 gives the best fit, although model 12 and the correlation model 23 fit the data almost as well. The common properties of these three Table 3 Siinmarv statisticsfor the two-week seizu1re counts. Within each groutp, the/irst columnin contains the mean and variance at each visit, followed by the correlatio,ns. models are that, in addition to their accounting for the rather strong within-subject covariance, the time-varying overdispersion is parameterized additively in their variances. The interaction between treatment and baseline seizure rate in these analyses produces a rather interesting result-namely, the predicted mean seizure rate for the progabide group is either higher or lower than that for the placebo group, accordingly as the baseline count does or does not exceed a critical threshold. This threshold varies between 11.2 and 15.2 seizures per 2-week period for the seven models considered, with the highest value corresponding to model 22. This suggests that progabide may be contraindicated for patients with high seizure rates. We regard this as a qualitative result, however, since it is based on a single data set and a particular family of models.
A visual scan of the data suggests that progabide patient #207 is an outlier, since both the baseline and posttreatment counts are much higher than those of the other patients. Deletion of this patient produces a marked drop in the means, variances, and correlations within the progabide group (Table 5) , although the extra-Poisson variation and withinsubject dependence are still substantial. While a comparison of these adjusted summary statistics with those of the placebo group suggests a greater treatment effect, deletion of this patient from the data has no clinical basis.
Plots of the standardized residuals ei, = (Yi, -',i1)/&i, for model 22 on the log baseline counts at each occasion (Figure 1) are perhaps more telling. In addition to the fact that each of the plots shows a random scatter, none of the residuals e = (el, e2, e3, e4) = (2.06, .58, .70, 1.32) of patient #207 are extreme. The largest residual at t = 1 is that of placebo patient #135, for whom e = (3.84, 2.99, .75, -1.32 ). This is due in part to the marked improvement of this patient over the course of the trial, as evidenced by the monotone decline in seizure count. The largest residual of 4.48 at t = 2 is due to progabide patient #225, while the two extreme residuals at t = 3 of 3.20 and 4.17 correspond to patients # 1 12 and #227, respectively. In each instance, a relatively large value of ei, is due to some deviation within subject from the predicted pattern over the four occasions. This phenomenon will arise almost invariably in any setting where a predictive model is fit to longitudinal data. The model thus accounts for the high dispersion in these data quite well, since none A referee has suggested estimating a in the present setting by adopting a pseudo-likelihood approach using the multivariate normal, and also via quasi-likelihood. For the first method, letting var(Y1) = o2V, for some covariance matrix V?, the pseudo-log-likelihood is 
i=l
Although minimization of (15) is apparently more involved than the naive moment estimation scheme given in Section 3, pseudo-likelihood may prove especially tractable for patterned covariance matrices having inverse and determinant that are computable in closed form. Again suppressing the index i for simplicity, each matrix corresponding to a cell in Table 1 These alternative methods for estimation of a raise a number of important issues, including those pertaining to comparisons of the statistical properties of the estimators under various formulations of V. Although such general questions of how second-order parameters are to be estimated are quite impor-tant, we do not pursue this issue further here.
As noted earlier, the correlation version of each model in column 2 of Table 1 allows one to account for the times (t, it) in modelling cov(Y,, Y1,), in addition to allowing these terms to be negative. This also may be accomplished by specifying a nondiagonal parametric form for cov(?) in the original formulation given in Section 2, rather than assuming that 1 I... I ., , are independent. If we denote Vo = diag,(,u), co = var(,y1), and assume for simplicity that all the random effects have mean 1, then reasoning as before, we obtain the generalization of (4) This provides a broader framework for modelling V, although we advocate as parsimonious a parameterization of cov(?) as is reasonable in a given setting.
The primary aim of the present article has been to propose a family of parametric models for the covariance matrix in the quasi-likelihood regression framework for longitudinal count data. As the above generalization shows, more complex versions of the models used here to fit the epilepsy data certainly are available, and quite possibly may give better fits. The data analyses presented in Section 5 are intended to provide a reasonably simple illustration of the general methodology, however, so that we have intentionally avoided using more elaborate versions of V. Still, the models presented in Table 1 comprise a broad collection of within-subject covariance structures, while each parameterization of V is rather parsimonious. Given the distributional results for both & and ,B, this provides a practical means for modelling both g and V in the generalized estimating equation setting.
